Last update:

Immunology news

Immunology

Organ-specific inflammation masquerades as relapse in CAR T-cell remission

Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg have identified a previously undocumented, organ-specific toxicity linked to CD19-targeted CAR T-cell therapy in autoimmune disease. The syndrome, termed ...

Immunology

Daylight can boost the immune system's ability to fight infections

A breakthrough study, led by scientists at Waipapa Taumata Rau, University of Auckland, has uncovered how daylight can boost the immune system's ability to fight infections.

Oncology & Cancer

Discovering new ways to recharge T-cells fighting cancer

A pair of recent studies from the laboratory of Bin Zhang, MD, Ph.D., the Johanna Dobe Professor of Cancer Immunology, have uncovered new details about critical biological processes that may help improve cancer treatments.

Medical research

Wastewater helps monitor cancer-causing HPV

Scientists in Uruguay have found genotypes of the human papillomavirus (HPV) linked to cervical cancer in urban wastewater, saying it could help inform disease prevention efforts.

Diseases, Conditions, Syndromes

Hidden diversity in fibroblasts may hold key to tissue repair

Fibroblasts play a central role in maintaining healthy tissue structures, as well as in the development and progression of diseases. For a long time, these specialized connective tissue cells were thought to represent a single, ...

Oncology & Cancer

'Obesity paradox' extends to cancer treatment, study finds

It's well-known that obesity is a risk factor for cardiovascular disease. But some research suggests that while people who are obese are more likely to develop cardiovascular problems, they're also less likely to die from ...

Diseases, Conditions, Syndromes

How the Epstein-Barr virus promotes its spread within the body

Many people are infected with the Epstein-Barr virus (EBV), and most are unaware of it. However, EBV can sometimes cause cancer, and this pathogen also appears to play an important role in multiple sclerosis and other autoimmune ...

Immunology

New B meningococcus vaccine shows promise in early-stage trial

The outcome of a trial published in Science Translational Medicine, shows encouraging results for a new vaccine targeting group B meningococcus (MenB), a significant cause of meningococcal disease worldwide, and establishes ...

Diseases, Conditions, Syndromes

Thetis cells identified as key player in childhood food allergies

A decade ago, a clinical trial in the U.K. famously showed that children who were exposed to peanuts in the early months of life had reduced risk of developing a peanut allergy compared with children who avoided peanuts.

Diseases, Conditions, Syndromes

Discovery may explain why more men are affected by severe COVID-19

Researchers at Umeå University, Sweden, have found another piece of the puzzle that explains why there are differences in immune responses in women and men when they get sick with COVID-19. This discovery has implications ...